XML 49 R40.htm IDEA: XBRL DOCUMENT v3.20.4
Share-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of Share-Based Compensation Expenses Related to Restricted Shares
The allocation of share-based compensation expense was as follows:
 
    
Year Ended
December 31,
    
Nine Months Ended September 30,
 
    
2019
    
2019
    
2020
 
    
RMB
    
RMB
    
RMB
    
US$ (Note 2.5)
 
Research and development expenses
     470        467        224,619        33,083  
Administrative expenses
     514,733        514,726        167,957        24,737  
    
 
 
    
 
 
    
 
 
    
 
 
 
    
 
515,203
 
  
 
515,193
 
  
 
392,576
 
  
 
57,820
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Summary of Stock Options Activities
The following table sets forth the stock options activities of 2017 Plan for the nine months ended September 30, 2020 is presented below:
 
    
Number of
shares
    
Weighted
average
exercise
price
US$
    
Weighted
average
remaining
contractual
term
    
Aggregate
intrinsic
value
US$
 
Outstanding as of December 31, 2019
     9,812,881        0.93        7.76        47,671  
Exercised
     (115,888      1.00        —          —    
Forfeited
     (336,377      1.00        —          —    
Surrendered (Note 15 (h))
     (332,566      1.00        —          —    
    
 
 
                            
Outstanding as of September 30, 2020
     9,028,050        0.93        7.01        175,576  
    
 
 
                            
Exercisable as of September 30, 2020
     8,047,548        0.92        6.91        156,567  
    
 
 
                            
Summary of Valuation Assumptions Used
The Group determined the fair value of the put right with the assistance of an independent third-party valuation firm. The Group used the option pricing model (finnerty model) to estimate the fair value of the put right using the following assumptions:
 
    
As of September 15,
and September 30,
 
    
2020
 
Expected terms (Year)
     4  
Estimated volatility
     55.2
Spot price
   US$ 143,401  
Probability of triggering event for redemption option
     65
2017 Plan [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Nonvested Share Activity [Table Text Block]
A summary of
non-vested
stock option activities for the nine months ended September 30, 2020 is presented below:
 
    
Number of
shares
    
Weighted average
Grant date fair value
US$
 
Non-vested
at December 31, 2019
     9,812,881        2.10  
Vested
     (8,047,548      1.74  
Exercised
     (115,888      2.14  
Forfeited
     (336,377      2.26  
Surrendered
     (332,566      1.47  
    
 
 
          
Non-vested
at September 30, 2020
     980,502        5.02  
    
 
 
          
2018 Plan [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of Stock Options Activities
The following table sets forth the stock options activities of 2018 Plan for the nine months ended September 30, 2020 is presented below:
 
    
Number of

shares
    
Weighted

average

exercise

price

US$
    
Weighted

average

remaining

contractual

term
    
Aggregate

intrinsic

value

US$
 
Outstanding as of December 31, 2019
     13,536,588        1.00        9.15        64,840  
Surrendered (Note 15 (h))
     (2,544,917      1.00        —          —    
    
 
 
                            
Outstanding as of September 30, 2020
     10,991,671        1.00        8.40        213.764  
    
 
 
                            
Exercisable as of September 30, 2020
     10,166,671        1.00        8.40        197,720  
    
 
 
                            
Schedule of Nonvested Share Activity [Table Text Block]
A summary of
non-vested
stock option activities for the nine months ended September 30, 2020 is presented below:
 
    
Number of
shares
    
Weighted
average

grant-date

fair value

US$
 
Non-vested
at December 31, 2019
     3,098,500        5.57  
Vested
     (2,273,500      5.57  
    
 
 
          
Non-vested
at September 30, 2020
     825,000        5.57  
    
 
 
          
2019 Plan [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of Stock Options Activities
The following table sets forth the stock options activities of 2019 Plan for the nine months ended September 30, 2020 presented:
 
    
Number of

shares
    
Weighted

average

exercise

price

US$
    
Weighted

average

remaining

contractual

term
    
Aggregate

intrinsic

value

US$
 
Outstanding as of December 31, 2019
     —          —          —          —    
Granted
     72,000        6.09        —          —    
    
 
 
                            
Outstanding as of September 30, 2020
     72,000        6.09        9.59        1,034  
    
 
 
                            
Exercisable as of September 30, 2020
     —          —          —          —    
    
 
 
                            
Summary of Valuation Assumptions Used
Stock options granted to the 3 independent directors were measured at fair value on the dates of grant using the Binomial Option Pricing Model with the following assumptions:
 
    
Nine Months Ended September 30,
 
    
2020
 
Expected volatility
     54.88
Risk-free interest rate (per annum)
     0.79
Exercise multiple
     2.80  
Expected dividend yield
     —    
Contractual term (in years)
     10  
Schedule of Nonvested Share Activity [Table Text Block]
A summary of
non-vested
stock options activity for the nine months ended September 30, 2020 is presented below:
 
    
Number of
shares
    
Weighted average

grant-date fair value

US$
 
Non-vested
at December 31, 2019
     —          —    
Granted
     72,000        6.09  
    
 
 
          
Non-vested
at September 30, 2020
     72,000        6.09  
    
 
 
          
2020 Plan [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of Stock Options Activities
The following table sets forth the stock options activities of 2020 Plan for the nine months ended September 30, 2020:
Summary of Valuation Assumptions Used
Stock options granted to the employees were measured at fair value on the dates of grant using the Binomial Option Pricing Model with the following assumptions:
 
    
Nine Months Ended September 30,
 
    
2020
 
Expected volatility
     56.51
Risk-free interest rate (per annum)
     0.86
Exercise multiple
    
2.20-2.80
 
Expected dividend yield
     —    
Contractual term (in years)
     10  
Schedule of Nonvested Share Activity [Table Text Block]
A summary of
non-vested
stock option activities for the nine months ended September 30, 2020 is presented below:
 
    
Number of
shares
    
Weighted average

grant-date fair value

US$
 
Non-vested
at December 31, 2019
     —          —    
Granted
     1,068,733        8.65  
Forfeited
     (18,693      8.65  
    
 
 
          
Non-vested
at September 30, 2020
     1,050,040        8.65  
    
 
 
          
Restricted Shares [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of Share-Based Compensation Expenses Related to Restricted Shares
Share-based compensation expenses related to restricted shares are included in:
 
    
Year Ended December 31,
    
Nine Months Ended September 30,
 
    
2019
    
  2019  
    
2020
 
    
RMB
    
RMB
    
RMB
    
US$ (Note 2.5)
 
Research and development expenses
     470        467        —          —    
Administrative expenses
     1,096        1,089        —          —    
  
 
 
    
 
 
    
 
 
    
 
 
 
     1,566        1,556        —          —    
  
 
 
    
 
 
    
 
 
    
 
 
 
Restricted Shares [Member] | 2018 Plan [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of Stock Options Activities
The following table sets forth the restricted share units subject to terms and conditions under 2018 Plan for the nine months ended September 30, 2020:
Schedule of Nonvested Restricted Stock Units Activity
A summary of
non-vested
restricted share units activities for the nine months ended September 30, 2020 is presented below:
 
    
Number of
restricted
share units
    
Weighted average

grant-date fair value

US$
 
Non-vested
at December 31, 2019
     —          —    
Granted
     1,328,120        13.34  
Vested
     (558,200      13.98  
    
 
 
          
Non-vested
at September 30, 2020
     769,920        12.88  
    
 
 
          
Restricted Shares [Member] | 2020 Plan [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of Stock Options Activities
The following table sets forth the restricted share units of 2020 Plan for the nine months ended September 30, 2020:
 
    
Number of

restricted
share units
    
Weighted

average

exercise

price

US$
    
Weighted

average

remaining

contractual

term
    
Aggregate

intrinsic

value

US$
 
Outstanding as of December 31, 2019
     —          —          —          —    
Granted
     3,564,798        —          —          —    
Forfeited
     (13,461      —          —          —    
    
 
 
                            
Outstanding as of September 30, 2020
     3,551,337        —          9.91        72,617  
    
 
 
                            
Schedule of Nonvested Restricted Stock Units Activity
A summary of
non-vested
restricted share units activities for the nine months ended September 30, 2020 is presented below:
 
    
Number of
restricted
share units
    
Weighted average

grant-date fair value

US$
 
Non-vested
at December 31, 2019
     —          —    
Granted
     3,564,798        13.63  
Forfeited
     (13,461      11.75  
    
 
 
          
Non-vested
at September 30, 2020
     3,551,337        13.68